April 8 (Reuters) - Lab equipment maker Waters said on Wednesday the U.S. Food and Drug Administration has cleared its ...

Waters Corporation (WAT) stock gains as the FDA clears the company's Onclarity HPV self-collection kit for use with BD’s (BDX ...

Waters Corporation (NYSE: WAT) today announced that the U.S. Food and Drug Administration (FDA) has cleared the Onclarity HPV ...

The US FDA approves Waters' at-home cervical cancer kit, insurers rise due to increased Medicare Advantage rates, and Kennedy plans a public health podcast. A Louisiana lawsuit against FDA abortion ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." Cervical cancer screening is about to get a lot more convenient. That’s because the latest cervical ...

The US FDA's approval of Waters' at-home cervical cancer screening kit marks a significant step in enhancing early detection and reducing fatalities. This move positively impacted Waters' stocks, ...

Individuals living in rural areas more likely to be diagnosed with later-stage cervical cancer, and 14% of the US population live in rurality. HealthDay News — American Cancer Society (ACS) guidelines ...

Waters Corporation WAT shares are up on Wednesday as the company announced FDA clearance for its Onclarity HPV ...

Home testing kits that screen for cervical cancer risk could be a game-changer for reducing health inequalities for ...

A Scottish woman shares her “embarrassment” over regularly ignoring pap smear reminders and worrying symptoms of heavy ...

Add Yahoo as a preferred source to see more of our stories on Google. Cervical cancer screening is about to get a lot more convenient. That’s because the latest cervical cancer screening guidelines ...

The Health Resources and Services Administration just released new guidelines for cervical cancer screenings, which include the approval of self-administered HPV tests. Women between age 30 and 65 ...